Handelsbanken Fonder AB Has $66.97 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Handelsbanken Fonder AB lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 193,818 shares of the company's stock after selling 2,571 shares during the quarter. Handelsbanken Fonder AB owned 0.08% of HCA Healthcare worth $66,974,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $36,000. Activest Wealth Management lifted its position in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares during the period. Legacy Investment Solutions LLC lifted its position in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after buying an additional 95 shares during the period. Finally, Physician Wealth Advisors Inc. bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $64,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Up 0.6%

NYSE:HCA traded up $2.27 on Wednesday, reaching $367.19. The company's stock had a trading volume of 1,026,667 shares, compared to its average volume of 1,449,044. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market cap of $88.34 billion, a PE ratio of 16.71, a PEG ratio of 1.10 and a beta of 1.49. The business's 50-day moving average price is $356.11 and its two-hundred day moving average price is $332.28.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $5.36 earnings per share. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.78%. HCA Healthcare's payout ratio is presently 12.81%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HCA. Guggenheim began coverage on HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Barclays set a $416.00 price objective on HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird restated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $392.47.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.